ArticleNanomedicine : nanotechnology, biology, and medicine2017

HER2-positive breast cancer targeting and treatment by a peptide-conjugated mini nanodrug.

Hui Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.